pravastatin has been researched along with Cardiometabolic Syndrome in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (72.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkaabi, M; Amoodi, AA; Baraka, MA; Don, J; Elnour, AA; Farah, FH; Mazrouei, NA; Ramadan, A; Sadeq, A; Sam, KG | 1 |
| Betteridge, DJ; Carmena, R | 1 |
| Chapman, MJ; Giral, P; Hounslow, N; Orsoni, A; Robillard, P; Sponseller, CA | 1 |
| Al-Hamaq, AO; Barakat, L; Bener, A; Dogan, M | 1 |
| Kokkola, T; Kuusisto, J; Laakso, M; López Rodríguez, M; Modi, S; Stančáková, A; Yaluri, N | 1 |
| Huang, CN; Lee, IT; Lee, WJ; Ou, HC; Sheu, WH | 1 |
| Ishihara, Y; Kohno, M; Kosaka, H; Mizukawa, M; Noma, T; Obayashi, A; Ohmori, K; Yoshida, J; Yukiiri, K | 1 |
| Amano, A; Daida, H; Kajimoto, K; Kasai, T; Kubota, N; Kurata, T; Miyauchi, K | 1 |
| Arnesen, H; Lappegård, KT; Mollnes, TE; Seljeflot, I; Trøseid, M | 1 |
| Hayashi, J; Hayashi, S; Maeda, S; Ohnishi, H; Sawayama, Y | 1 |
| Ichikawa, S; Ishikura, N; Kamiyama, K; Matsushima, T; Mizuno, K; Nakamura, H; Nakaya, N; Ohashi, Y; Teramoto, T; Yokoyama, S | 1 |
| Cobbe, SM; Ford, I; Gaw, A; Haffner, SM; Isles, C; Macfarlane, PW; O'Reilly, DS; Packard, CJ; Sattar, N; Scherbakova, O; Shepherd, J | 1 |
| Aronow, WS | 1 |
| Güçlü, F; Hekimsoy, Z; Kirmaz, C; Ozmen, B | 1 |
| Bays, HE; Blasetto, JW; Cain, VA; Deedwania, PC; Hunninghake, DB; Jones, PH | 1 |
| Gil'mutdinova, LT; Syrtlanova, ER | 1 |
| Asselbergs, FW; Bakker, SJ; de Jong, PE; Geluk, CA; Hillege, HL; van Gilst, WH; Zijlstra, F | 1 |
| Forouhi, NG; Sattar, N | 1 |
| Barter, P; Kallend, D; Schuster, H; Stender, S; Watkins, C | 1 |
| Matsui, T; Sato, T; Takeuchi, M; Yamagishi, S | 1 |
| Field, KM | 1 |
| Boccara, F; Capeau, J; Gharakhanian, S | 1 |
| Knopp, RH; Paramsothy, P | 1 |
| Blauw, GJ; Buckley, BM; de Craen, AJ; Ford, I; Forouhi, NG; Freeman, DJ; Jukema, JW; Lennon, L; Macfarlane, PW; McConnachie, A; Murphy, MB; Packard, CJ; Sattar, N; Shaper, AG; Shepherd, J; Stott, DJ; Wannamethee, SG; Westendorp, RG; Whincup, PH | 1 |
| Kinoshita, M; Matsumoto, T; Matsuo, S; Nakamura, Y; Takahashi, M | 1 |
4 review(s) available for pravastatin and Cardiometabolic Syndrome
| Article | Year |
|---|---|
A Systematic Review of Randomized Clinical Trials on the Efficacy and Safety of Pitavastatin.
Topics: Atorvastatin; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Pravastatin; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin | 2023 |
Diabetogenic Action of Statins: Mechanisms.
Topics: Aged; Animals; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Insulin; Male; Metabolic Syndrome; Mice; Middle Aged; Pravastatin; Quinolines; Risk Factors | 2019 |
Hypercholesterolemia. The evidence supports use of statins.
Topics: Aged; Cholesterol, HDL; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metabolic Syndrome; Pravastatin; Simvastatin | 2003 |
Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on high-sensitivity C-reactive protein levels.
Topics: Animals; Atherosclerosis; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Metabolic Syndrome; Pravastatin; Pyrroles; Risk Factors; Simvastatin | 2005 |
7 trial(s) available for pravastatin and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies.
Topics: Blood Glucose; Cholesterol, LDL; Cohort Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Quinolines; Triglycerides | 2014 |
The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome.
Topics: Adult; Cardiovascular Diseases; Combined Modality Therapy; Exercise Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interleukin-18; Male; Metabolic Syndrome; Middle Aged; Pravastatin | 2009 |
Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.
Topics: Aged; Anticholesteremic Agents; Asian People; Azetidines; Cholesterol; Clinical Chemistry Tests; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Metabolic Syndrome; Middle Aged; Pravastatin; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Triglycerides | 2010 |
The effect of low-dose pravastatin in metabolic syndrome for primary prevention of cardiovascular disease in Japan: a post hoc analysis of the MEGA study.
Topics: Adult; Aged; Anticholesteremic Agents; Cardiovascular Diseases; Combined Modality Therapy; Coronary Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Japan; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Primary Prevention | 2012 |
Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Atorvastatin; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome | 2005 |
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
Topics: Albuminuria; Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Survival Analysis | 2005 |
Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
Topics: Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Metabolic Syndrome; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
14 other study(ies) available for pravastatin and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome.
Topics: Adult; Atorvastatin; Cost-Benefit Analysis; Diabetes Mellitus; Dyslipidemias; Female; Humans; Hypolipidemic Agents; Lipids; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Rosuvastatin Calcium; Simvastatin; Socioeconomic Factors | 2014 |
Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Colforsin; Cyclic AMP; Diabetes Mellitus; Erythrocyte Membrane; Fatty Acids; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Secretion; Male; Metabolic Syndrome; Mice; Middle Aged; Pancreas; Pravastatin; Receptors, G-Protein-Coupled; Risk Factors; Signal Transduction; Simvastatin | 2015 |
Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Glucose; C-Reactive Protein; Cell Adhesion; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Monocytes; Patient Selection; Pravastatin; Triglycerides; Young Adult | 2009 |
Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
Topics: Adiponectin; Adipose Tissue, White; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Cardiovascular System; Drug Therapy, Combination; Eating; Glucose Intolerance; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lipids; Male; Metabolic Syndrome; Nitric Oxide Synthase Type III; Oxidation-Reduction; Pravastatin; Rats; Rats, Inbred OLETF; RNA, Messenger; Superoxides; Tetrahydrofolate Dehydrogenase; Tetrazoles | 2009 |
The impact of pravastatin therapy on long-term outcome in patients with metabolic syndrome undergoing complete coronary revascularization.
Topics: Aged; Asian People; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Middle Aged; Myocardial Revascularization; Pravastatin; Proportional Hazards Models; Risk Factors; Time Factors; Treatment Outcome | 2009 |
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
Topics: Body Mass Index; C-Reactive Protein; Cohort Studies; Comorbidity; Coronary Disease; Diabetes Mellitus; Follow-Up Studies; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Obesity; Pravastatin; Predictive Value of Tests; Risk Assessment; Scotland; Triglycerides | 2003 |
Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.
Topics: Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Metabolic Syndrome; Middle Aged; Pravastatin | 2004 |
[Effect of eprosartan in combination with pravastatin on some parameters of endothelial function in patients with metabolic syndrome.].
Topics: Humans; Metabolic Syndrome; Pravastatin | 2004 |
Metabolic syndrome criteria: ready for clinical prime time or work in progress?
Topics: Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Pravastatin; Randomized Controlled Trials as Topic | 2005 |
Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome; Triglycerides | 2005 |
Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Models, Biological; Models, Theoretical; Obesity; Pravastatin | 2006 |
Statins in HIV-associated lipodystrophy and metabolic syndrome: is there a missing link?
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Pravastatin; Treatment Outcome | 2006 |
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Geriatrics; Humans; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Pravastatin; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors | 2008 |
Detection of coronary microvascular disease by means of cardiac scintigraphy.
Topics: Aged; Cardiac Catheterization; Chest Pain; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Isosorbide Dinitrate; Metabolic Syndrome; Perindopril; Pravastatin; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |